Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical diclofenac penetration into the hip joint in osteoarthritis patients undergoing total hip arthroplasty
2017-000178-13Phase 4Terminated
- Sponsor
- The Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust
- Start
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of diclofenac diethylammonium in hip osteoarthritis and osteoarthritis (OA), sponsored by The Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust. Primary endpoints: Diclofenac concentration in synovium and Diclofenac concentration in synovial fluid. Started Feb 2017; status: terminated.
02
Drugs
diclofenac diethylammonium
03
Conditions
hip osteoarthritisosteoarthritis (OA)
Beyond the preview
Go deeper on 2017-000178-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-000178-13.